This inventor holds 1 USPTO granted patent. Top assignee: University of Manitoba. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Samaneh Afshar Delkhah: Innovator in Optical Cytometry
Introduction
Samaneh Afshar Delkhah is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of optical cytometry, particularly through her innovative patent. Her work focuses on advancing the analysis of single cells, which is crucial for various applications in biomedical research.
Latest Patents
Samaneh holds a patent for a "Parallel single cell lens free optical dielectrophoresis cytometer." This invention features a dual light source lens-free dielectrophoresis (DEP) flow cytometer designed for massively parallel single cell analysis. The technology infers each cell's dielectric properties by measuring their altitude and the subsequent velocity change due to DEP actuation in a microfluidic channel. The use of dual LED sources allows for precise velocity measurement by creating two shadows for each cell as it passes through the channel. These shadows are detected using a linear optical array detector, enabling independent analysis of each passing cell. The DEP cytometer is composed of simple modular components, which allows for scalability and the potential to achieve a significantly high throughput label-free single-cell analyzer.
Career Highlights
Samaneh is affiliated with the University of Manitoba, where she continues to develop her research and innovations. Her work has garnered attention for its potential impact on the field of cytometry and single-cell analysis.
Collaborations
Some of her notable coworkers include Douglas John Thomson and Azita Fazelkhah, who contribute to her research endeavors and collaborative projects.
Conclusion
Samaneh Afshar Delkhah is a pioneering inventor whose work in optical cytometry is paving the way for advancements in single-cell analysis. Her innovative patent demonstrates her commitment to enhancing biomedical research through technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
